5 Einträge gefunden

1. Loss of CDKN1B/p27Kip1 expression is associated with ERG fusion-negative prostate cancer, but is unrelated to patient prognosis

   1. Sirma, Hüseyin
   2. Broemel, Margarethe
   3. Stumm, Laura
   4. Tsourlakis, Maria Christina
   5. Steurer, Stefan
   6. Tennstedt, Pierre
   7. Salomon, Georg

   2013 - Forschungsinformationssystem des UKE
2. Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions

   1. Kluth, Martina
   2. Hesse, Jana
   3. Heinl, Anna
   4. Krohn, Antje
   5. Steurer, Stefan
   6. Sirma, Hüseyin
   7. Simon, Ronald

   2013 - Forschungsinformationssystem des UKE
3. SPINK1 expression is tightly linked to 6q15- and 5q21-deleted ERG-fusion negative prostate cancers but unrelated to PSA recurrence

   1. Grupp, Katharina
   2. Diebel, Franz
   3. Sirma, Hüseyin
   4. Simon, Ronald
   5. Breitmeyer, Karin
   6. Steurer, Stefan
   7. Hube-Magg, Claudia

   2013 - Forschungsinformationssystem des UKE
4. Strong expression of the neuronal transcription factor FOXP2 is linked to an increased risk of early PSA recurrence in ERG fusion-negative cancers.

   1. Stumm, Laura
   2. Burkhardt, Lia
   3. Steurer, Stefan
   4. Simon, Ronald
   5. Adam, Meike
   6. Becker, Andreas
   7. Sauter, Guido

   2013 - Forschungsinformationssystem des UKE
5. Cysteine-rich secretory protein 3 overexpression is linked to a subset of PTEN-deleted ERG fusion-positive prostate cancers with early biochemical recurrence.

   1. Grupp, Katharina
   2. Kohl, Sebastian
   3. Sirma, Hüseyin
   4. Simon, Ronald
   5. Steurer, Stefan
   6. Becker, Andreas
   7. Adam, Meike

   2013 - Forschungsinformationssystem des UKE